193 related articles for article (PubMed ID: 19665222)
1. The effect of osteoprotegerin gene modification on wear debris-induced osteolysis in a murine model of knee prosthesis failure.
Zhang T; Yu H; Gong W; Zhang L; Jia T; Wooley PH; Yang SY
Biomaterials; 2009 Oct; 30(30):6102-8. PubMed ID: 19665222
[TBL] [Abstract][Full Text] [Related]
2. Cell-based osteoprotegerin therapy for debris-induced aseptic prosthetic loosening on a murine model.
Zhang L; Jia TH; Chong AC; Bai L; Yu H; Gong W; Wooley PH; Yang SY
Gene Ther; 2010 Oct; 17(10):1262-9. PubMed ID: 20428210
[TBL] [Abstract][Full Text] [Related]
3. Adeno-associated virus-mediated osteoprotegerin gene transfer protects against particulate polyethylene-induced osteolysis in a murine model.
Yang SY; Mayton L; Wu B; Goater JJ; Schwarz EM; Wooley PH
Arthritis Rheum; 2002 Sep; 46(9):2514-23. PubMed ID: 12355500
[TBL] [Abstract][Full Text] [Related]
4. Recombinant adeno-associated virus-mediated osteoprotegerin gene therapy inhibits wear debris-induced osteolysis.
Ulrich-Vinther M; Carmody EE; Goater JJ; S balle K; O'Keefe RJ; Schwarz EM
J Bone Joint Surg Am; 2002 Aug; 84(8):1405-12. PubMed ID: 12177271
[TBL] [Abstract][Full Text] [Related]
5. Combination gene therapy targeting on interleukin-1β and RANKL for wear debris-induced aseptic loosening.
Wang H; Jia TH; Zacharias N; Gong W; Du HX; Wooley PH; Yang SY
Gene Ther; 2013 Feb; 20(2):128-35. PubMed ID: 22318091
[TBL] [Abstract][Full Text] [Related]
6. Murine model of prosthesis failure for the long-term study of aseptic loosening.
Yang SY; Yu H; Gong W; Wu B; Mayton L; Costello R; Wooley PH
J Orthop Res; 2007 May; 25(5):603-11. PubMed ID: 17278141
[TBL] [Abstract][Full Text] [Related]
7. TNF-α suppression and osteoprotegerin overexpression inhibits wear debris-induced inflammation and osteoclastogenesis in vitro.
Peng L; Zhang H; Zhou Y; Li W; Jiang P; Zhang Y; Song K
Int J Artif Organs; 2015 Oct; 38(10):565-71. PubMed ID: 26541276
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of ex vivo OPG gene therapy in preventing wear debris induced osteolysis.
Goater JJ; O'Keefe RJ; Rosier RN; Puzas JE; Schwarz EM
J Orthop Res; 2002 Mar; 20(2):169-73. PubMed ID: 11918293
[TBL] [Abstract][Full Text] [Related]
9. MMP-9 inhibition suppresses wear debris-induced inflammatory osteolysis through downregulation of RANK/RANKL in a murine osteolysis model.
Chen D; Zhang X; Guo Y; Shi S; Mao X; Pan X; Cheng T
Int J Mol Med; 2012 Dec; 30(6):1417-23. PubMed ID: 23027468
[TBL] [Abstract][Full Text] [Related]
10. Gene therapy methods in bone and joint disorders. Evaluation of the adeno-associated virus vector in experimental models of articular cartilage disorders, periprosthetic osteolysis and bone healing.
Ulrich-Vinther M
Acta Orthop Suppl; 2007 Apr; 78(325):1-64. PubMed ID: 17427340
[TBL] [Abstract][Full Text] [Related]
11. Titanium particle-challenged osteoblasts promote osteoclastogenesis and osteolysis in a murine model of periprosthestic osteolysis.
Jiang Y; Jia T; Gong W; Wooley PH; Yang SY
Acta Biomater; 2013 Jul; 9(7):7564-72. PubMed ID: 23518478
[TBL] [Abstract][Full Text] [Related]
12. Suppression of polyethylene particle-induced osteolysis by exogenous osteoprotegerin.
von Knoch F; Heckelei A; Wedemeyer C; Saxler G; Hilken G; Brankamp J; Sterner T; Landgraeber S; Henschke F; Löer F; von Knoch M
J Biomed Mater Res A; 2005 Nov; 75(2):288-94. PubMed ID: 16088891
[TBL] [Abstract][Full Text] [Related]
13. Cepharanthine ameliorates titanium particle-induced osteolysis by inhibiting osteoclastogenesis and modulating OPG/RANKL ratio in a murine model.
Liao L; Lin Y; Liu Q; Zhang Z; Hong Y; Ni J; Yu S; Zhong Y
Biochem Biophys Res Commun; 2019 Sep; 517(3):407-412. PubMed ID: 31376931
[TBL] [Abstract][Full Text] [Related]
14. Strontium ranelate reduces the progression of titanium particle-induced osteolysis by increasing the ratio of osteoprotegerin to receptor activator of nuclear factor-κB ligand in vivo.
Geng T; Sun S; Chen X; Wang B; Guo H; Zhang S; Jin Q
Mol Med Rep; 2018 Mar; 17(3):3829-3836. PubMed ID: 29257329
[TBL] [Abstract][Full Text] [Related]
15. Protection against titanium particle-induced inflammatory osteolysis by the proteasome inhibitor bortezomib in vivo.
Mao X; Pan X; Zhao S; Peng X; Cheng T; Zhang X
Inflammation; 2012 Aug; 35(4):1378-91. PubMed ID: 22391745
[TBL] [Abstract][Full Text] [Related]
16. Protective effects of IL-1Ra or vIL-10 gene transfer on a murine model of wear debris-induced osteolysis.
Yang SY; Wu B; Mayton L; Mukherjee P; Robbins PD; Evans CH; Wooley PH
Gene Ther; 2004 Mar; 11(5):483-91. PubMed ID: 14724688
[TBL] [Abstract][Full Text] [Related]
17. Particulate and ion forms of cobalt-chromium challenged preosteoblasts promote osteoclastogenesis and osteolysis in a murine model of prosthesis failure.
Yang S; Zhang K; Jiang J; James B; Yang SY
J Biomed Mater Res A; 2019 Jan; 107(1):187-194. PubMed ID: 30358096
[TBL] [Abstract][Full Text] [Related]
18. Melittin Treats Periprosthetic Osteolysis in a Rat Model by Inhibiting the NF-kB Pathway and Regulating the Ratio of Receptor Activator of Nuclear Factor Kappa B Ligand/Osteoprotegerin.
Niu J; Bi F; Tian Q; Tian K
J Arthroplasty; 2024 Jul; 39(7):1845-1855. PubMed ID: 38336308
[TBL] [Abstract][Full Text] [Related]
19. Lentivirus-mediated TNF-α gene silencing and overexpression of osteoprotegerin inhibit titanium particle-induced inflammatory response and osteoclastogenesis in vitro.
Peng L; Wang H; Song K; Wang H; Liu P
Mol Med Rep; 2016 Jan; 13(1):1010-8. PubMed ID: 26648171
[TBL] [Abstract][Full Text] [Related]
20. Protection against titanium particle induced osteolysis by cannabinoid receptor 2 selective antagonist.
Geng D; Xu Y; Yang H; Wang J; Zhu X; Zhu G; Wang X
Biomaterials; 2010 Mar; 31(8):1996-2000. PubMed ID: 20004468
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
